BZAM Ltd (BZAMF)
0.0000
0.00 (0.00%)
USD |
OTCM |
Nov 15, 16:00
BZAM Revenue (Quarterly): 15.68M for Sept. 30, 2023
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | 15.68M |
| June 30, 2023 | 14.34M |
| March 31, 2023 | 17.81M |
| December 31, 2022 | 12.68M |
| September 30, 2022 | 7.599M |
| June 30, 2022 | 9.099M |
| March 31, 2022 | 8.344M |
| December 31, 2021 | 7.51M |
| September 30, 2021 | 5.78M |
| June 30, 2021 | 6.600M |
| Date | Value |
|---|---|
| March 31, 2021 | 4.252M |
| December 31, 2020 | 5.291M |
| September 30, 2020 | 2.253M |
| June 30, 2020 | 3.190M |
| March 31, 2020 | 2.186M |
| December 31, 2019 | 2.372M |
| September 30, 2019 | 1.911M |
| June 30, 2019 | 2.164M |
| March 31, 2019 | 1.809M |
| December 31, 2018 | 1.421M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
2.186M
Minimum
Mar 2020
17.81M
Maximum
Mar 2023
7.812M
Average
7.055M
Median
Revenue (Quarterly) Benchmarks
| Medical International Technology Inc | -- |
| Biosyntech Inc | -- |
| Cotinga Pharmaceuticals Inc | -- |
| The Flowr Corp | 1.412M |
| Canntab Therapeutics Ltd | -0.0164M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -11.67M |
| Total Expenses (Quarterly) | 25.31M |
| EPS Diluted (Quarterly) | -0.0671 |